
Organ chip technology enables precise prediction of chemotherapy response in esophageal cancer patients
Esophageal adenocarcinoma (EAC) is one of the two main types of esophageal cancer and ranks as the sixth deadliest
Esophageal adenocarcinoma (EAC) is one of the two main types of esophageal cancer and ranks as the sixth deadliest
An eight-year clinical trial conducted by the HonorHealth Research Institute has demonstrated a major breakthrough in treating structural shock
Emergency department (ED) presentations are linked with increased cancer mortality, but there is limited evidence regarding patients with malignant
Copyright © 2025 Medipreneur. All rights reserved.